|
Real-time Estimate
Cboe BZX
17:12:41 29/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 7.860 USD | +2.68% |
|
-24.48% | -34.68% |
| 09-15 | Ocular Therapeutix, Inc. Completes Pre-NDA Meeting With FDA For AXPAXLI In Wet AMD | CI |
| 09-15 | Ocular Therapeutix Plans to File Eye Disease Drug Marketing Application in Q4 | MT |
| Market Cap | 1.68B 1.48B 1.4B 1.27B 2.38B 161B 2.4B 16.74B 6.47B 82.35B 6.31B 6.18B 265B | P/E 2026 * |
-5.13x | P/E 2027 * | -5.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.3B 1.15B 1.08B 983M 1.85B 125B 1.86B 12.98B 5.01B 63.83B 4.89B 4.79B 205B | EV / Sales 2026 * |
24.6x | EV / Sales 2027 * | 15.8x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCUL | Delayed | |
CBOE
| OCUL | Real-time | |
|
Tradegate
| 0OT | Real-time | |
|
Boerse Muenchen
| 0OT | Real-time | |
|
Börse Stuttgart
| 0OT | Delayed | |
|
Deutsche Boerse AG
| 0OT | Delayed | |
|
Berne S.E.
| 0OT | End-of-day quote |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | +2.35% | ||
| 1 week | -24.48% | ||
| Current month | -24.40% | ||
| 1 month | -24.40% | ||
| 3 months | -19.90% | ||
| 6 months | +7.16% | ||
| Current year | -34.68% |
| 1 week | 7.18 |  | 10.57 |
| 1 month | 7.18 | | 11.48 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 14/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 19/01/2026 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 19/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 30/06/2019 |
| Director/Board Member | 78 | 04/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 19/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Sell | Chief Operating Officer | -1,099 | 0.0005% | ||
| 25/08/26 | Don | Chief Executive Officer | -100,184 | 0.0473% | ||
| 24/08/26 | Sell | Executive/Senior Manager | -3,035 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.68% | -24.48% | -36.71% | +152.55% | 1.68B | |
| -0.60% | +0.39% | +61.69% | +118.69% | 1,056B | |
| -1.92% | -0.77% | +47.07% | +71.50% | 655B | |
| -1.27% | -0.72% | +17.98% | +76.64% | 471B | |
| -1.72% | -4.06% | +36.39% | +39.47% | 342B | |
| -0.40% | +3.83% | +22.08% | +28.82% | 277B | |
| -0.51% | -1.93% | +12.09% | +11.94% | 257B | |
| -0.26% | +1.65% | +52.21% | +55.16% | 226B | |
| -1.57% | -1.86% | +33.04% | +99.93% | 189B | |
| -0.24% | -2.76% | -28.41% | -60.92% | 170B | |
| Average | -0.66% | -1.46% | +21.74% | +59.38% | 364.46B | |
| Weighted average by Cap. | -1.08% | +1.03% | +38.22% | +69.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.93M 46.55M 44.02M 39.93M 74.98M 5.08B 75.42M 527M 204M 2.59B 199M 194M 8.33B | 102M 90.13M 85.23M 77.3M 145M 9.84B 146M 1.02B 394M 5.02B 385M 376M 16.13B |
| Net income | -334M -294M -278M -252M -474M -32.09B -476M -3.33B -1.29B -16.37B -1.26B -1.23B -52.62B | -324M -285M -270M -245M -460M -31.14B -462M -3.23B -1.25B -15.89B -1.22B -1.19B -51.06B |
| Net Debt | -378M -332M -314M -285M -536M -36.28B -539M -3.76B -1.45B -18.52B -1.42B -1.39B -59.5B | -66M -58.05M -54.89M -49.79M -93.5M -6.34B -94.04M -657M -254M -3.23B -248M -242M -10.39B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | US$7.900 | +3.20% | 1,933,849 |
| 28/09/26 | US$7.655 | -20.67% | 15,442,389 |
| 25/09/26 | US$9.650 | -1.73% | 1,621,507 |
| 24/09/26 | US$9.820 | -1.80% | 1,864,662 |
| 23/09/26 | US$10.00 | -4.76% | 2,089,389 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
